Fact CheckerSign in

NCT05242952Completed

The LEARN Study for CVD Prevention

LEveraging A viRtual eNvironment (LEARN) to Enhance Prevention of HIV-related Comorbidities in At-risk Minority MSM

Source: ClinicalTrials.gov · Last updated 16 Jul 2026

Brief summary (registry, in English)

The investigator is testing a virtual environment (VE) to address prevention of HIV-related comorbidities.

Status (registry)
Completed
Study type
Interventional
Enrollment
78 (actual)
First submitted
28 Oct 2020
Start date
10 May 2023
Primary completion date
31 Mar 2025
Lead sponsor
Yale University
Diseases
HIV
NCT number
NCT05242952

What you commit to

  • Study type: Interventional
  • Participants enrolled: 78
  • From 10 May 2023 to the primary completion date, 31 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Anything outside of inclusion parameters, including history of:
  • myocardial infarction (MI)
  • congestive heart failure (CHF)
  • cognitive impairment

Other

  • coronary artery bypass graft (CABG)
  • cerebral vascular accident (CVA)

Who the study is looking for

  • identify as an ethnic/racial minority with HIV
  • identify as gay, same-gender-loving, or MSM
  • able to read and understand English
  • access to a computer capable of downloading and running the VE software
  • no medical history of serious cardiovascular or cognitive complications

Age in the registry: 30 years to 65 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yale University
Coordinator of this site? Confirm its status		OrangeUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.